RSV Vaccines May Be Linked to Small Increased Risk of Developing Guillain-Barre Syndrome, Data Suggests

February 29, 2024

a close up of a syringe with liquid

(STAT News) – The new vaccines that protect older adults against respiratory syncytial virus, or RSV, may be linked to a small increased risk of developing Guillain-Barré syndrome, new data from the Centers for Disease Control and Prevention and the Food and Drug Administration suggest. (Read More)